Profiles of Cancer Stem Cell Subpopulations in Cholangiocarcinomas
- 1 June 2015
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 185 (6) , 1724-1739
Abstract
No abstract availableKeywords
Funding Information
- Agenzia Regionale del Lazio per i Trapianti e le Patologie Connesse
- FIRB (#RBAP10Z7FS_001, RBAP10Z7FS_004)
- Sapienza University of Rome
- NIH (DK58411, DK062975)
- Vesta Therapeutics
- Dow Chemical Company
- NIH (1R21CA182322-01)
- NIH Cancer Center (CA016086)
This publication has 34 references indexed in Scilit:
- The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro StudyPLOS ONE, 2013
- Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneityWorld Journal of Gastrointestinal Oncology, 2012
- Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineagesJournal of Anatomy, 2011
- LGR5 Is a Negative Regulator of Tumourigenicity, Antagonizes Wnt Signalling and Regulates Cell Adhesion in Colorectal Cancer Cell LinesPLOS ONE, 2011
- Strong expression of CD133 is associated with increased cholangiocarcinoma progressionWorld Journal of Gastroenterology, 2011
- Nestin in gastrointestinal and other cancers: Effects on cells and tumor angiogenesisWorld Journal of Gastroenterology, 2011
- CD13 is a therapeutic target in human liver cancer stem cellsJournal of Clinical Investigation, 2010
- Microenvironmental regulation of metastasisNature Reviews Cancer, 2008
- Human hepatic stem cells from fetal and postnatal donorsJournal of Experimental Medicine, 2007
- A Tumorigenic Subpopulation with Stem Cell Properties in MelanomasCancer Research, 2005